How 4D Molecular Therapeutics, Inc. stacks up

FDMT · against 481 other Healthcare companies of similar size

Profitability

11/ 100

Near the bottom of its peers.

Ranked #430 of 482 · scores higher than 10% of peers

Bars: peers in each 10-point band of the profitability score

47 peers with a profitability score of 10–19, including FDMT · Click a bar to see the companies

Why profitability scores 11?

Weighted metrics compared with all Healthcare companies.

Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.

a thinner operating margin: weaker than 90% of peers. Operating margin: -214.2% vs peer median 7.1%
a lower return on assets: weaker than 89% of peers. Return on assets: -36.4% vs peer median 1.7%
a lower return on invested capital: weaker than 86% of peers. Return on invested capital: -43.6% vs peer median 4.7%

Metric by metric

Position: dot = FDMT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	FDMT	Peer median	Better than	Weight
Return on invested capitalHigher is better · 457 reported	-43.6%	2.7%	13%	33%
Operating marginHigher is better · 451 reported	-214.2%	5.0%	8%	33%
Return on assetsHigher is better · 476 reported	-36.4%	1.0%	10%	33%
Return on equityHigher is better · 456 reported	-43.3%	1.6%	15%	Context only
Gross marginHigher is better · 498 reported	-157.7%	42.6%	1%	Context only

Ranking by profitability score

Top 5 and the companies ranked around FDMT

Rank	Company	Market cap	Profitability	Overall
1	Procter & Gamble Health LimitedPGHL.NS · India	97.3B INR (≈$1.2B)	100	80
2	Arbutus Biopharma CorporationABUS · US-listed	595M USD	99	97
2	CorMedix Inc.CRMD · US-listed	433M USD	99	81
2	Ironwood Pharmaceuticals, Inc.IRWD · US-listed	578M USD	99	73
2	MeiraGTx Holdings plcMGTX · US-listed	914M USD	99	81
⋯
424	Prothena Corporation plcPRTA · US-listed	421M USD	12	52
424	Rezolute, Inc.RZLT · US-listed	388M USD	12	36
424	Syndax Pharmaceuticals, Inc.SNDX · US-listed	1.3B USD	12	33
430	DiaMedica Therapeutics Inc.DMAC · US-listed	539M USD	11	33
430	4D Molecular Therapeutics, Inc.FDMT · US-listed	660M USD	11	43
430	Immix Biopharma, Inc.IMMX · US-listed	552M USD	11	39
430	LB Pharmaceuticals IncLBRX · US-listed	1.3B USD	11	39
430	AVITA Medical, Inc.RCEL · US-listed	474M USD	11	25
430	SpyGlass Pharma, Inc.SGP · US-listed	1.2B USD	11	40

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…